Lonza | LONN - Market Capitalization


Lonza reported CHF41.44B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akzo Nobel EUR 10.15B 1.73B Jun/2026
Alcon AG USD 37.06B 5.98B Mar/2026
Almirall EUR 2.76B 472.53M Dec/2025
AstraZeneca USD 178.16B 111.83B Aug/2026
BASF EUR 41.75B 5.02B Jun/2026
Bayer EUR 49.51B 10.82B Aug/2026
Beiersdorf EUR 22.73B 3.43B Dec/2025
Covestro EUR 12.54B 1.53B Dec/2025
Demant DKK 46.01B 10.48B Dec/2025
Fresenius EUR 26.29B 3.78B Aug/2026
Fresenius Medical Care EUR 11.32B 642.58M Mar/2026
Geberit CHF 21.02B 759.86M Dec/2025
Genmab DKK 126.96B 21.8B Aug/2026
Givaudan CHF 29.05B 6.42B Dec/2025
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
GN Store Nord DKK 15.22B 890.39M Mar/2026
Hikma Pharmaceutical USD 3.49B 1.14B Aug/2026
Merck EUR 62.96B 16.17B Aug/2026
Novartis USD 240.59B 67.17B Jun/2026
Philips EUR 23.09B 615.44M Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Sika AG CHF 26.09B 8.47B Dec/2025
Smith & Nephew USD 3.54B 9.16B Aug/2026
Solvay EUR 2.76B 8.17M Aug/2026
UCB EUR 46.41B 13.94B Dec/2025